Articles:

Masood A. Shammas, Robert J. Shmookler Reis, Masaharu Akiyama, Hemanta Koley, Dharminder Chauhan, Teru Hideshima, Raj K. Goyal, Laurence H. Hurley, Kenneth C. Anderson, and Nikhil C. Munshi

Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma
Mol Cancer Ther 2003 2: 825-833. [Abstract] [Full Text] [PDF]  

Simon Williams, Curtis Pettaway, Rendu Song, Christos Papandreou, Christopher Logothetis, and David J. McConkey

Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts
Mol Cancer Ther 2003 2: 835-843. [Abstract] [Full Text] [PDF]  

Gordon R. Macpherson, Sylvia S.W. Ng, Siiri L. Forbes, Giovanni Melillo, Tatiana Karpova, James McNally, Thomas P. Conrads, Timothy D. Veenstra, Alfredo Martinez, Frank Cuttitta, Douglas K. Price, and William D. Figg

Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assay
Mol Cancer Ther 2003 2: 845-854. [Abstract] [Full Text] [PDF]  

John M. Fidler, Ke Li, Cathie Chung, Ke Wei, Jessica A. Ross, Mingxing Gao, and Glenn D. Rosen

PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy
Mol Cancer Ther 2003 2: 855-862. [Abstract] [Full Text] [PDF]  

Yajaira Suárez, Laura González, Ana Cuadrado, Maite Berciano, Miguel Lafarga, and Alberto Muñoz

Kahalalide F, a new marine-derived compound, induces oncosis in human prostate and breast cancer cells
Mol Cancer Ther 2003 2: 863-872. [Abstract] [Full Text] [PDF]  

Deepak Sampath, Carolyn M. Discafani, Frank Loganzo, Carl Beyer, Hao Liu, Xingzhi Tan, Sylvia Musto, Tami Annable, Patricia Gallagher, Carol Rios, and Lee M. Greenberger

MAC-321, a novel taxane with greater efficacy than paclitaxel and docetaxel in vitro and in vivo
Mol Cancer Ther 2003 2: 873-884. [Abstract] [Full Text] [PDF]  

Pamela L. Rice, Jennifer Kelloff, Holly Sullivan, Linda J. Driggers, K. Scott Beard, Scott Kuwada, Gary Piazza, and Dennis J. Ahnen

Sulindac metabolites induce caspase- and proteasome-dependent degradation of ß-catenin protein in human colon cancer cells
Mol Cancer Ther 2003 2: 885-892. [Abstract] [Full Text] [PDF]  

Juan C. Acosta, Carlos Richard, M. Dolores Delgado, Machiko Horita, M. Giulia Rizzo, Jose L. Fernández-Luna, and Javier León

Amifostine impairs p53-mediated apoptosis of human myeloid leukemia cells
Mol Cancer Ther 2003 2: 893-900. [Abstract] [Full Text] [PDF]  

Rachel L. Cowen, Adam V. Patterson, Brian A. Telfer, Rachel E. Airley, Steve Hobbs, Roger M. Phillips, Mohammed Jaffar, Ian J. Stratford, and Kaye J. Williams

Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenografts
Mol Cancer Ther 2003 2: 901-909. [Abstract] [Full Text] [PDF]  

Hiroaki Goto, Bo Yang, Denise Petersen, Karen A. Pepper, Paul A. Alfaro, Donald B. Kohn, and C. Patrick Reynolds

Transduction of green fluorescent protein increased oxidative stress and enhanced sensitivity to cytotoxic drugs in neuroblastoma cell lines
Mol Cancer Ther 2003 2: 911-917. [Abstract] [Full Text] [PDF]  

Robert A. Gatenby and Thomas L. Vincent

Application of quantitative models from population biology and evolutionary game theory to tumor therapeutic strategies
Mol Cancer Ther 2003 2: 919-927. [Abstract] [Full Text] [PDF]  

Meeting Report:

Miriam S. Gitler, Anne Monks, and Edward A. Sausville

Preclinical models for defining efficacy of drug combinations: mapping the road to the clinic
Mol Cancer Ther 2003 2: 929-932. [Full Text] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.